StockSelector.com
  Research, Select, & Monitor Saturday, October 20, 2018 9:19:15 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Ironwood Pharmaceuticals, Inc.$16.71($.44)(2.57%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Ironwood Pharmaceuticals, Inc. has an overall rank of 6589 out of 7245 stocks based on 6 positive rankings and 11 negative rankings.

Positive Rankings
SSValue
The StockSelector Value for Ironwood Pharmaceuticals is $545.49. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Ironwood Pharmaceuticals is ranked 37.
PEGValue
Ironwood Pharmaceuticals has a PEG Value of $141.88. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 749.08% in the next year. Among companies with a PEG Value above the current stock price, Ironwood Pharmaceuticals is ranked 87.
Estimated Revenue Growth
Ironwood Pharmaceuticals rank is 579
Historic Revenue Growth
Ironwood Pharmaceuticals rank is 941
Low Put/Call
Ironwood Pharmaceuticals has a low Put/Call ratio of 0.39 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Ironwood Pharmaceuticals is ranked 969.
Oversold Stochastics
Ironwood Pharmaceuticals rank is 1956
Negative Rankings
Price-to-Book
Ironwood Pharmaceuticals rank is 17
Debt-to-Equity
Ironwood Pharmaceuticals rank is 28
Negative ROE
Ironwood Pharmaceuticals rank is 33
Price-to-Sales
Ironwood Pharmaceuticals rank is 594
Negative Net Margin
Ironwood Pharmaceuticals rank is 656
Down EPS Surprise
Ironwood Pharmaceuticals missed the consensus earnings estimate when it last reported quarterly earnings.
Negative ROA
Ironwood Pharmaceuticals rank is 938
Negative Cash Growth
Ironwood Pharmaceuticals rank is 1279
10 Day Loss
Ironwood Pharmaceuticals rank is 1812
High vPut/Call
Ironwood Pharmaceuticals has a high Put/Call ratio of 0.45 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Ironwood Pharmaceuticals is ranked 2224.
90 Day Loss
Ironwood Pharmaceuticals rank is 2236







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.